Latest California Healthline Stories
‘Game-Changing’ Guidelines In Calif. Try To Relieve Some Of Burden From An Alzheimer’s Diagnosis
The California Department of Public Health has issued new guidelines to help primary care physicians, nurse practitioners and physician assistants better diagnose and document the disease, explain it to patients and direct them to community-based programs and services.
Despite Higher Cost Of Living In San Diego, Doctor Pay Lower Than Other Coastal Areas
Medicare reimbursement rates could be partly to blame for the disparity.
Can $200 Really Buy You An Accurate Look At Your Genetic Risk For Diseases?
California-based 23andMe, a genetic testing company, recently won FDA approval to sell its product, which tells users if they are susceptible to certain diseases. Stat offers a look at what consumers need to know about it before considering using it.
The Health Law’s Unlikely Defenders: Republicans
As Republican efforts to dismantle and replace the Affordable Care Act continue, some in the party are actually speaking out for provisions in the legislation, such as coverage for people with pre-existing conditions.
Lawmakers Shift Focus To Transparency To Curb High Drug Costs
A bill, scheduled for a hearing April 19 in the Senate Committee on Health, would require companies to announce and explain any large increase in costs.
Program Targeting High Teen Suicide Rates Launches In Palo Alto
The program will offer teens support in addition to weekly or monthly therapy.
Many In State’s Health Care Professions Are Immigrants
The Sacramento Bee offers a breakdown of the percentage of immigrants in medical careers and other industries.
Patient’s Own Immune Cells Contribute To Memory Loss After Surgery, Study Finds
More than 10 percent of surgery patients 60 years and older show some degree of mental impairment three months following surgery.
In Turnaround, FDA To Allow Genetic Tests To Be Sold To Consumers
The decision to let California-based 23andMe sell saliva-testing kits that report on markers for 10 diseases is expected to open the floodgates for more at-home tests for disease risks.
FDA’s Process Dinged For Being ‘Burdensome And Slow,’ But It’s Faster Than Its European Counterpart
Dr. Scott Gottlieb, President Donald Trump’s pick to head the Food and Drug Administration, has been focused on what he’ll do to speed up the drug approval process to make it more like Europe. But the FDA is actually faster already.